Genetic testing in women diagnosed with breast cancer decreases cost of care nationwide
A new study suggests that Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the U.S. by about $50 million (about 2 percent of the overall costs in the first year). The study by ...
Apr 24, 2019
0
4